The effects of T4 and A3/R phage preparations on whole-Blood monocyte and neutrophil respiratory burst

Viral Immunology

Volumn 23, Issue 5, 2010, Pages 541-544

  Borysowski, Jan ^a   Wierzbicki, Piotr ^a   Kłosowska, Danuta ^a   Korczak Kowalska, Grazyna ^a,b   Weber Da̧browska, Beata ^c   Górski, Andrzej ^a,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE A3/R; BACTERIOPHAGE T4; BLOOD CELL; CELL LYSATE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MONOCYTE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

BACTERIOPHAGES; HUMANS; MONOCYTES; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 77957737127     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0001     Document Type: Article

References (15)

1. Boratyński J, Syper D, Weber-Da̧browska B, Łusiak-Szelachowska M, Poźniak G, and Górski A: Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 2004;9:253-259.
2. Chavakis T, Preissner KT, and Herrmann M: The antiinflammatory activities of Staphylococcus aureus. Trends Immunol 2007;28:408-418
3. Hanlon GW: Bacteriophages: an appraisal of their role in the treatment of bacterial infections Int J Antimicrob Agents 2007;30:118-128.
4. Miȩdzybrodzki R, Świtała-Jeleń K, Fortuna W, et al.: Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes. Virus Res 2008;131:233-242.
5. Przerwa A, Zimecki M, Switala-Jeleń K, et al.: Effects of bacteriophages on free radical production and phagocytic functions. Med Microbiol Immunol 2006;195:143-150.
6. Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, and Sulakvelidze A: Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care 2009;18:237-243.
7. Richardson MP, Ayliffe MJ, Helbert M, and Davies EG: A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J Immunol Methods 1998;219:187-193.
8. Schwarz KB: Oxidative stress during viral infection: a review. Free Radic Biol Med 1996;21:641-649.
9. Smith HW, and Huggins MB: Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982;128:307-318.
10. Ślopek S, Durlakowa I, Weber-Da̧browska B, et al.: Results of bacteriophage treatment of suppurative bacterial infections. I: General evaluation of the results. Arch Immunol Ther Exp 1983;31:267-291.
11. Victor VM, Rocha M, and De La Fuente M: Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004;4:327-347.
12. Weber-Da̧browska B, and Mulczyk M, Górski A: Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp 2000;48:547-551.
13. Westphal O, and Jann K: Bacterial lipopolysaccharides: Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965;5:83-89.
14. Wright A, Hawkins CH, Anggard EE, and Harper DR: A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 2009;34:349-357.
15. Zimecki M, Weber-Da̧browska B, Łusiak-Szelachowska M, et al.: Bacteriophages provide regulatory signals in mitogeninduced murine splenocyte proliferation. Cell Mol Biol Lett 2003;8:699-697.